Menu Menu

CDTX    Cidara Therapeutics Inc    1610618    
Income Statement
Revenue 2,826,000
Net Income -169,827,000
Profit Margin -6009.45%

Balance Sheet
Current Assets 210,737,000
Assets 214,796,000
Current Liabilities 49,554,000
Liabilities 51,488,000
Equity 163,308,000
Shares Out 7,038,000

Cash Flow Statement
Operating Cash Flow -176,533,000
Investing Cash Flow -129,000

Market Analysis
Market Cap 83,403,158
Price 22.58
BVPS 23.20
PB 0.97
EPS -25.30
PS 7.38
FCF -176,662,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/6 -26.75
Apr May Jun
4/22 -0.04 5/15 -2.28
Jul Aug Sep
8/13 0.66
Oct Nov Dec
11/05

Find a discrepancy? The most accurate way to find company fundamental data is to view CDTX documents filed with the SEC.


CDTX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: